| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/07/2010 | US20100003286 Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 01/07/2010 | US20100003281 antigenic determinant comprising a polypeptide sequence from hepatitis E virus open reading frame 2 ; drug screening |
| 01/07/2010 | US20100003280 Adjuvant compositions |
| 01/07/2010 | US20100003269 Methods and uses of cauliflower and collard for recombinant protein production |
| 01/07/2010 | US20100003262 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 01/07/2010 | US20100003260 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 01/07/2010 | US20100003256 Use of TGF-Beta Antagonists in Treatment of Parathyroid-Related Disorders |
| 01/07/2010 | US20100003251 Uses of IL-23 Agonists and Antagonists; Related Reagents |
| 01/07/2010 | US20100003240 Cancer treatment with endothelin receptor antagonists |
| 01/07/2010 | US20100003238 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 01/07/2010 | US20100003237 In vivo temporal control of activatable matrix-degrading enzymes |
| 01/07/2010 | US20100003236 Use of c-glycoside derivatives as pro-desquamating active agents |
| 01/07/2010 | US20100003235 Oral formulations for enteric disorders and/or rehydration |
| 01/07/2010 | US20100003234 Cellulase activity; used to make bioethanol, in food and textile treatment, in waste treatment; breaks down lignocellulose |
| 01/07/2010 | US20100003233 Compositions and methods for treatment of microbial infections |
| 01/07/2010 | US20100003232 Insulin-degrading enzyme mutants and methods of use |
| 01/07/2010 | US20100003231 Polymers of fluorinated monomers and hydrocarbon monomers |
| 01/07/2010 | US20100003230 tRNA SYNTHETASE FRAGMENTS |
| 01/07/2010 | US20100003229 Nuclear telomerase reverse transcriptase variant |
| 01/07/2010 | US20100003225 Hsp60, hsp60 peptides and t cell vaccines for immunomodulation |
| 01/07/2010 | US20100003224 Combination Therapy |
| 01/07/2010 | US20100003217 Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections |
| 01/07/2010 | US20100003216 HCV NS-3 Serine Protease Inhibitors |
| 01/07/2010 | US20100003215 Culturing circular ssDNA viruses for the production of vaccines |
| 01/07/2010 | US20100003214 Quinoxaline-containing compounds as hepatitis c virus inhibitors |
| 01/07/2010 | US20100003213 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 01/07/2010 | US20100003195 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 01/07/2010 | DE102008032828A1 Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel Tryptophan-containing peptides from alpha-lactalbumin with antihypertensive and vasoprotective effect for biofunctional food |
| 01/07/2010 | DE102008031284A1 Neue Bekämpfungsmöglichkeit der Giardiose New fighting chance of giardiasis |
| 01/07/2010 | DE102008031283A1 Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten New way of combating diseases caused by Trichomonadida |
| 01/07/2010 | CA2729868A1 Anti- p2x7 peptides and epitopes |
| 01/07/2010 | CA2729810A1 Tgf-.beta. antagonist multi-target binding proteins |
| 01/07/2010 | CA2729780A1 Methods and compositions for reducing inflammation and treating inflammatory disorders |
| 01/07/2010 | CA2729764A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | CA2729749A1 Tnf-a antagonist multi-target binding proteins |
| 01/07/2010 | CA2729730A1 Use of nifurtimox for treating giardiasis |
| 01/07/2010 | CA2729727A1 Nifurtimox for treating diseases caused by trichomonadida |
| 01/07/2010 | CA2729414A1 Vaccine against amyloid folding intermediate |
| 01/07/2010 | CA2728877A1 Method of treating hearing loss using xiap |
| 01/07/2010 | CA2727698A1 A therapeutic agent for a lower urinary tract disease and an agent for improving a lower urinary tract symptom |
| 01/07/2010 | CA2724523A1 Novel macrocyclic peptides |
| 01/06/2010 | EP2141234A1 Short Interfering RNA (siRNA) Analogues |
| 01/06/2010 | EP2141231A1 METHOD FOR INHIBITION OF SIGNALING THROUGH ErbB2, SIGNALING INHIBITOR FOR USE IN THE METHOD, AND USE OF THE SIGNALING INHIBITOR |
| 01/06/2010 | EP2141178A1 Method of producing antithrombin composition |
| 01/06/2010 | EP2141146A1 Calcilytic compounds |
| 01/06/2010 | EP2140881A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 01/06/2010 | EP2140876A1 Therapeutic agent comprising vasohibin |
| 01/06/2010 | EP2140875A1 Compositions and methods for healthy pregnancy |
| 01/06/2010 | EP2140874A1 Remedy for acute hepatitis or preventive/remedy for fulminant hepatitis |
| 01/06/2010 | EP2140873A1 Method for producing an antitumoral vaccine based on surface endothelial cell antigens |
| 01/06/2010 | EP2140863A1 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of neurological disorders |
| 01/06/2010 | EP2140015A2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
| 01/06/2010 | EP2140003A2 Sample-processing reagent compositions, methods, and devices |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2139992A1 A method of modulating the activity of a nucleic acid molecule |
| 01/06/2010 | EP2139917A2 Anti-androgen peptides and uses thereof in cancer therapy |
| 01/06/2010 | EP2139916A1 Toll-like receptor binding epitope and compositions for binding thereto |
| 01/06/2010 | EP2139913A2 Inducing immune-mediated tumor cell death |
| 01/06/2010 | EP2139525A1 Fusion protein capable of degrading amyloid beta peptide |
| 01/06/2010 | EP2139511A1 Pharmaceutical composition comprising a cytokine |
| 01/06/2010 | EP2139508A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/06/2010 | EP2139500A1 Device which enhances the biological activity of locally applied growth factors with particular emphasis on those used for bone repair |
| 01/06/2010 | EP2139458A1 A biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof |
| 01/06/2010 | EP2139447A2 Gm-csf cosmeceutical compositions and methods of use thereof |
| 01/06/2010 | EP2139337A1 Inhibitors of fibroblast activation protein, and methods of use thereof |
| 01/06/2010 | EP2139318A1 Fusion proteins with cleavable spacers and uses thereof |
| 01/06/2010 | EP1697401B1 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 01/06/2010 | EP1461073B1 Peptide agonists of prostate-specific antigen, and uses therefor |
| 01/06/2010 | EP1427713B1 Benzothiazepine derivatives for the treatment of hyperlipidemia |
| 01/06/2010 | EP1404360B1 Monodisperse mixtures of calcitonin drug-oligomer conjugates comprising polyethylene glycol, uses thereof, and methods of making same |
| 01/06/2010 | EP1355944B1 Rtvp based compositions and methods for the treatment of prostate cancer |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | EP1062243B1 Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments |
| 01/06/2010 | EP1005361B1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ENDOTHELIAL DYSFUNKTION AND FOR THE INHIBITION OF ANGIOGENESIS RESPECTIVELY |
| 01/06/2010 | EP0963197B1 Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/06/2010 | CN101622007A Native (telopeptide) placental collagen compositions |
| 01/06/2010 | CN101622006A Use of VEGF in the treatment of retarded fetal growth in pregnancy |
| 01/06/2010 | CN101618210A Staphylococcus lysozyme local sustained release preparation, preparation method and application thereof |
| 01/06/2010 | CN101618209A Local sustained release preparation for preventing and treating osteomyelitis, preparation method and application thereof |
| 01/06/2010 | CN101618208A Method for preparing sustained-release microspheres containing micronized recombinant human vascular endothelial inhibin |
| 01/06/2010 | CN101618207A Application of polypeptide in preparing ACE inhibitor and medicine for lowering blood pressure |
| 01/06/2010 | CN101618206A Composition for sobering up and protecting liver |
| 01/06/2010 | CN101618049A Treatment of neoplasms with viruses |
| 01/06/2010 | CN100578227C TTK in diagnosis and as a therapeutic target in cancer |
| 01/06/2010 | CN100577804C Novel mutant allergens |
| 01/06/2010 | CN100577686C Oligomeric peptides and their use for the treatment of HIV infections |
| 01/06/2010 | CN100577685C Long-acting thymosin alpha1 polyethylene glycol modifier |
| 01/06/2010 | CN100577652C Method for synthesizing esters of N-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
| 01/06/2010 | CN100577212C Function of E4BP4 gene in embryo implantation course and application thereof |
| 01/06/2010 | CN100577206C Controlled release composition and method of producing the same |
| 01/06/2010 | CN100577205C Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions prepared therefrom |
| 01/06/2010 | CN100577203C Use of urease for inhibiting cancer cell growth |
| 01/06/2010 | CN100577202C Pharmacological vitreous body dissolving operation |
| 01/06/2010 | CN100577201C Treatment of diabetes |
| 01/06/2010 | CN100577200C Medicine preparation for treating cow's mammitis and its preparation and use |
| 01/06/2010 | CN100577175C Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/06/2010 | CN100577149C Novel lyophilization protecting agent prescription of A type botulinum toxin freeze-dried powder injection preparation for treatment |
| 01/05/2010 | US7643943 Methods for monitoring drug activities in vivo |
| 01/05/2010 | US7642903 Trailer tire alert system |